Description
The National Heart, Lung, and Blood Institute convened a Working Group of investigators on August 5-6, 2004, in Bethesda, Maryland, to assess the current status of Phase I/II clinical studies of cell based therapies for cardiovascular disease; determine the gaps in knowledge and barriers that prevent the implementation of well designed, safe clinical studies and trials; identify the areas of opportunity for application of cell based therapies for cardiovascular disease; and facilitate the clinical implementation of cell based therapies for cardiovascular disease.